Fas-mediated apoptosis in cultured human eosinophils

Blood

Volumn 87, Issue 7, 1996, Pages 2822-2830

  Druilhe, Anne ^b   Cai, Zhenzi ^b   Hailé, Solomon ^b   Chouaib, Salem ^b   Pretolani, Marina ^a  

^a INSTITUT PASTEUR   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; FAS ANTIGEN; MESSENGER RNA; MONOCLONAL ANTIBODY;

APOPTOSIS; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; CROSS LINKING; EOSINOPHIL; GENE EXPRESSION; HUMAN; HUMAN CELL; MACROPHAGE; PHAGOCYTOSIS; PRIORITY JOURNAL;

EID: 0029937933     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v87.7.2822.bloodjournal8772822     Document Type: Article

References (45)

1. Kroegel C, Warner JA, Virchow J-C, Matthys H: Pulmonary immune cells in health and disease: The eosinophil leucocyte (part II). Eur Respir J 7:743, 1994
2. Butterfield JH, Leiferman KM: Eosinophil-associated diseases, in Smith H, Cook RM (eds): Immunopharmacology of Eosinophils. London, UK, Academic, 1993, p 151
3. Holgate ST: Asthma: Past, present and future. Eur Respir J 6:1507, 1993
4. Wardlaw AJ, Dunnette S, Gleich GJ, Collins JV, Kay AB: Eosinophils and mast cells in bronchoalveolar lavage in subjects with mild asthma. Relationship to bronchial hyperreactivity. Am Rev Respir Dis 137:62, 1988
5. Kroegel C, Virchow J-C, Luttmann W, Walker C, Warner JA: Pulmonary immune cells in health and disease: The eosinophil leucocyte (part I). Eur Respir J 7:519, 1994
6. Resnick MB, Weller PF: Mechanisms of eosinophil recruitment. Am Rev Respir Dis 8:349, 1993
7. Valerius T, Repp R, Kalden JR, Platzer E: Effects of IFN on human eosinophils in comparison with other cytokines. A novel class of eosinophil activators with delayed onset of action. J Immunol 145:2950, 1990
8. Yamaguchi Y, Suda T, Ohta S, Tominaga K, Miura Y, Kasahara T: Analysis of the survival of mature human eosinophils: Interleukin-5 prevents apoptosis in mature human eosinophils. Blood 78:2542, 1991
9. Majno G, Joris I: Apoptosis, oncosis, and necrosis. An overview of cell death. Am J Pathol 146:3, 1995
10. Wyllie AH: Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature 284:555, 1990
11. Cosman D: A family of ligands for the TNF receptor superfamily. Stem Cells 12:440, 1994
12. Krammer PH, Dhein J, Walczak H, Behrmann I, Mariani S, Matiba B, Fath M, Daniel PT, Knipping E, Westendorp MO, Stricker K, Bäumler C, Hellbardt S, Germer M, Peter M, Debatin K-M: The role of APO-1-mediated apoptosis in the immune system. Immunol Rev 142:175, 1994
13. Matsue H, Kobayashi H, Hosokawa T, Akitaya T, Ohkawara A: Keratinocytes constitutively express the Fas antigen that mediates apoptosis in IFN gamma-treated cultured keratinocytes. Arch Dermatol Res 287:315, 1995
14. Richardson BC, Lalwani ND, Johnson KJ, Marks RM: Fas ligation triggers apoptosis in macrophages but not endothelial cells. Eur J Immunol 24:2640, 1995
15. Alderson MR, Armitage RJ, Maraskovsky E, Tough TW, Roux E, Schooley K, Ramsdell F, Lynch DH: Fas transduces activation signals in normal human T-lymphocytes. J Exp Med 178:2231, 1993
16. Russell JH, Rush B, Weaver C, Wang R: Mature T cells of autoimmune lpr/lpr mice have a defect in antigen-stimulated suicide. Proc Natl Acad Sci USA 90:4409, 1993
17. Hansel TT, Pound JD, Pilling D, Kitas GD, Salmon M, Gentle TA, Lee SS. Thompson RA: Purification of human blood eosinophils by negative selection using immunomagnetic beads. J Immunol Methods 122:97, 1989
18. Stern M, Meagher L, Savill J, Haslett C: Apoptosis in human eosinophils. Programmed cell death in the eosinophil leads to phagocytosis by macrophages and is modulated by IL-5. J Immunol 148:3543, 1992
19. Martin JHJ, Edwards SW: Changes in mechanisms of monocyte/macrophage-mediated cytotoxicity during culture. Reactive oxygen intermediates are involved in monocyte-mediated cytotoxicity, whereas reactive nitrogen intermediates are employed by macrophages in tumor cell killing. J Immunol 150:314, 1993
20. Nicoletti I, Migliorati G, Pagliacci MC, Grignani F, Riccardi C: A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J Immunol Methods 139:271, 1991
21. Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156, 1987
22. Saito T, Knowles A, Li MS, Sun L, Tooze JA, Zabucchi G, Spry CJF: Expression of lacto-N-fucopentaose 3 (CD15)- and sialyl-Lewis X-bearing molecules and their functional properties in eosinophils from patients with idiopathic hypereosinophilic syndrome. Immunology 83:313, 1994
23. Smith CA, Williams GT, Kingston R, Jenkinson EJ, Owen JJT: Antibodies to CD3/T-cell receptor complex induce death by apoptosis in immature T cells in thymic cultures. Nature 337:181, 1989
24. Newman SL, Henson JE, Henson PM: Phagocytosis of senescent neutrophils by human monocyte-derived macrophages and rabbit inflammatory macrophages. J Exp Med 156:430, 1982
25. Gleich GJ, Frigas E, Loegering DA, Wassom DL, Steinmuller D: Cytotoxic properties of the eosinophil major basic protein. J Immunol 123:2925, 1979
26. Cox G, Crossley J, Xing Z: Macrophage engulfment of apoptotic neutrophils contributes to the resolution of acute pulmonary inflammation in vivo. Am J Respir Cell Mol Biol 12:232, 1995
27. Dhein J, Walczak H, Bäumer C, Debatin K-M, Krammer PH: Automne T-cell suicide mediated by APO-1 (Fas/CD95). Nature 373:438, 1995
28. Brunner T, Mogil RJ, Laface D, Yoo MJ, Mahboubi A, Echeverri F, Martin SJ, Force WR, Lynch DH, Ware CF, Green DR: Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas. Nature 373:441, 1995
29. Lagasse E, Weissman IL: bcl-2 inhibits apoptosis of neutrophils but not their engulment by macrophages. J Exp Med 179:1047, 1994
30. Hawkins CJ, Vaux DL: Analysis of the role of bcl-2 in apoptosis. Immunol Rev 142:127, 1994
31. Nunez G, London L, Hockenbery D, Alexander M, McKearn JP, Korsmeyer S: Deregulated bcl2 gene expression selectively prolongs survival of growth factor-deprived hemopoietic cell lines. J Immunol 144:3602, 1990
32. Yoshino T, Kondo E, Cao L, Takahashi K, Hayashi K, Nomura S, Akagi T: Inverse expression of bcl-2 protein and Fas antigen in lymphoblasts in peripheral lymph nodes and activated peripheral blood T and B lymphocytes. Blood 83:1856, 1994
33. + thymocytes by the anti-Fas antibody. J Exp Med 181:485, 1995
34. Crispe IN: Fatal interactions: Fas-induced apoptosis of mature T cells. Immunity 1:347, 1995
35. Owen-Schaub LB, Yonehara S, Crump WL III, Grimm EA: DNA fragmentation and cell death is selectively triggered in activated human lymphocytes by Fas antigen engagement. Cell Immunol 140:197, 1992
36. Miyawaki T, Uehara T, Nibu R, Tsuji T, Yachie A, Yonehara S, Taniguchi N: Differential expression of apoptosis-related Fas antigen on lymphocyte subpopulations in human peripheral blood. J Immunol 149:3753, 1992
37. Shima Y, Nishimoto N, Ogata A, Fujii Y, Yoshizaki F, Kishimoto T: Myeloma cells express Fas antigen/APO-1 (CD95), but only some are sensitive to anti-Fas antibody resulting in apoptosis. Blood 85:757, 1995
38. Savill J, Dransfield I, Hogg N, Haslett C: Vitronectin receptor mediated phagocytosis of cells undergoing apoptosis. Nature 343:170, 1990
39. Schleimer RP: Effects of glucocorticosteroids on inflammatory cells relevant to their therapeutical applications in asthma. Am Rev Respir Dis 141:859, 1990
40. Muller M, Renkawitz R: The glucocorticoid receptor. Biochim Biophys Acta 1088:171, 1991
41. Barnes PJ, Adcock I: Anti-inflammatory actions of steroids. Molecular mechanisms. Trends Pharmacol Sci 14:436, 1993
42. Leung DYM, Martin RJ, Szefler SJ, Sher ER, Ying S, Kay AB, Hamid Q: Dysregulation of interleukin 4, interleukin 5, and Interferon γ gene expression in steroid resistant asthma. J Exp Med 181:33, 1995
43. 2+ -dependent endonuclease in thymocyte nuclei leads to cell death. J Immunol 132:38, 1984
44. Wallen N, Kita H, Weiler D, Gleich GJ: Glucocorticoids inhibit cytokine-mediated eosinophil survival. J Immunol 147:3490, 1991
45. Simon H-U, Blaser K: Inhibition of programmed eosinophil death: A key pathogenic event for eosinophilia? Immunol Today 16:53, 1995